"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Aldurazyme Patient Information including How Should I Take
In this Article
- What is laronidase (Aldurazyme)?
- What are the possible side effects of laronidase (Aldurazyme)?
- What is the most important information I should know about laronidase (Aldurazyme)?
- What should I discuss with my healthcare provider before receiving laronidase (Aldurazyme)?
- How should I use laronidase (Aldurazyme)?
- What happens if I miss a dose (Aldurazyme)?
- What happens if I overdose (Aldurazyme)?
- What should I avoid while receiving laronidase (Aldurazyme)?
- What other drugs will affect laronidase (Aldurazyme)?
- Where can I get more information?
What should I discuss with my healthcare provider before receiving laronidase (Aldurazyme)?
You should not use laronidase if you are allergic to it.
To make sure laronidase is safe for you, tell your doctor if you have any of these other conditions:
- fever or cold symptoms (cough, sore throat, chest congestion, sinus pain, runny or stuffy nose, sneezing);
- heart disease;
- kidney disease;
- asthma or other lung disease;
- epilepsy or other seizure disorder;
- migraine headaches; or
- if you have sleep apnea and you use a continuous positive airway pressure (CPAP) machine.
You may be encouraged to join a patient registry while you are using this medication. The purpose of this registry is to track the progression of this disorder and the effects that laronidase has on long-term treatment of MPS I.
FDA pregnancy category B. Laronidase is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
If you are pregnant, your name may be listed on a pregnancy registry. This is to track the outcome of the pregnancy and to evaluate any effects of laronidase on the baby.
It is not known whether laronidase passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I use laronidase (Aldurazyme)?
Laronidase is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting.
The medicine must be given slowly through an IV infusion, and can take up to 4 hours to complete.
Laronidase is usually given once per week. Follow your doctor's instructions very carefully.
Tell your doctor if you have been sick with a fever, head cold, chest cold. You may need to wait until you get better before receiving your dose of laronidase.
Your doctor may also prescribe other medications to help prevent an allergic reaction to laronidase. Take all of your medications as directed.
Your doctor will need to check your progress on a regular basis. Do not miss any scheduled appointments.
Additional Aldurazyme Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.